For malignancy | HBME-1 | Galectin-3 | CK19 | CD56 |
---|---|---|---|---|
Sensitivity | 71.31 % | 88.52 % | 75.41 % | 58.20 % |
Specificity | 84.81 % | 64.56 % | 70.89 % | 92.41 % |
Positive Likelihood Ratio | 4.69 | 2.5 | 2.59 | 7.66 |
Negative Likelihood Ratio | 0.34 | 0.18 | 0.35 | 0.45 |
Disease prevalence | 60.70 % | 60.70 % | 60.70 % | 60.70 % |
Positive Predictive Value | 87.88 % | 79.41 % | 80.00 % | 92.21 % |
Negative Predictive Value | 65.69 % | 78.46 % | 65.12 % | 58.87 % |
Odds ratio | 13.8786 | 14.051 | 7.4667 | 16.9379 |